The Aba Chemicals Corporation(300261) (300261), whose share price soared more than four times in the first three months of the year, will resume trading from the opening of the market tomorrow (February 6) after the suspension and verification.
According to the Aba Chemicals Corporation(300261) announcement, it did not supply Pfizer with the company’s products, nor could it be determined whether the raw materials for Pfizer covid-19 oral medicine used the company’s products.
However, the orders of Aba Chemicals Corporation(300261) carbonic anhydride products on hand did increase significantly, indicating strong market demand. According to Aba Chemicals Corporation(300261) , other manufacturers in the industry have plans to expand production, and Aba Chemicals Corporation(300261) will make plans to expand production according to the actual situation in the future.
it is not determined whether Pfizer uses the company’s products
Aba Chemicals Corporation(300261) is an enterprise mainly providing pesticide intermediates and pharmaceutical intermediates. The stock is sought after, mainly related to Pfizer covid-19 oral drug concept.
The raw material of Pfizer covid-19 oral medicine contains carbonic anhydride, which is just Aba Chemicals Corporation(300261) able to produce carbonic anhydride.
Previously, in response to the letter of concern from the exchange, Aba Chemicals Corporation(300261) said that carbonic anhydride and its derivatives can be used to synthesize Pfizer covid-19 oral drug palovide from the process flow, in which carbonic anhydride and its derivatives refer to compounds rather than products produced by the company, It cannot be determined that the carbonic anhydride and its derivatives produced by the company can be used to synthesize Pfizer covid-19 oral drug.
Aba Chemicals Corporation(300261) also clarified that it has no business contact and cooperation with Pfizer, has not signed a cooperation agreement with Pfizer, has not supplied carlon anhydride products to Pfizer, and Pfizer has not provided the company with any quality standards for the purchase of covid-19 oral front-end raw materials.
And the customer refused to provide the end use of purchasing Aba Chemicals Corporation(300261) carbonic anhydride and its derivatives, so it is uncertain whether the carbonic anhydride products produced by Aba Chemicals Corporation(300261) meet the needs of Pfizer products.
Relevant technical validation has not been carried out, and it is impossible to determine whether the Kalon anhydride product produced by Aba Chemicals Corporation(300261) is or can become Pfizer covid-19 oral drug intermediate.
orders on hand increased significantly
Although Aba Chemicals Corporation(300261) has repeatedly said that it has no direct business contact with Pfizer, the market is still highly concerned.
In fact, the revenue of carbonic anhydride and its derivatives accounts for a low proportion of the revenue of Aba Chemicals Corporation(300261) , but the orders on hand do increase significantly.
According to the information disclosed by Aba Chemicals Corporation(300261) , the sales revenue of carbonic anhydride and its derivatives in 2021 was 27.073 million yuan, accounting for about 1% – 2% of the total annual operating revenue.
By the end of 2021, Aba Chemicals Corporation(300261) carbonic anhydride and derivatives had orders on hand amounting to 63.54 million yuan, more than twice the business revenue in 2021.
The obvious increase of orders on hand of Aba Chemicals Corporation(300261) shows that the short-term market demand is high. In this context, other manufacturers in the industry are also ready to take a share.
According to Aba Chemicals Corporation(300261) , other manufacturers in the industry plan to invest in the construction of production lines of carbonic anhydride and its derivatives, and the design capacity is much higher than the existing capacity of Aba Chemicals Corporation(300261) .
According to the scale effect, after other manufacturers put into large-scale production, the production cost is expected to be lower than the product production cost of Aba Chemicals Corporation(300261) , which may lead to Aba Chemicals Corporation(300261) facing risks such as loss of orders, reduction of revenue and decline of profitability.
In view of the above situation, Aba Chemicals Corporation(300261) is also studying the expansion of production of carbonic anhydride and its derivatives. Aba Chemicals Corporation(300261) said that when the downstream market situation of carbonic anhydride and its derivatives becomes clear, the company will make planning and prudent decision on whether to expand production. At present, the company has not decided whether to expand production, and there is still great uncertainty about whether to expand production in the end.
